Elderly hypertension has distinct pathophysiological features requiring individualized, gradual pharmacological management to prevent cardiovascular events while maintaining quality of life.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Haneda et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: